Back

Single-cell analysis of an adult IBD INCEPTION cohort reveals Galectin-linked disease mechanisms

Leipner, M.; Rimmer, P.; Tull, S.; Paun, A.; Sandrin, V.; Begum, J.; Mansour, A. A.; Saviano, A.; Sharma, N.; Cheesbrough, J.; Maione, F.; Trenkle, P.; Klein, A.; Danilin, S.; Iqbal, T. H.; Iqbal, A. J.; Regan-Komito, D.

2026-07-03 immunology
10.64898/2026.06.30.735473 bioRxiv
Show abstract

Background and Aims: The molecular pathogenesis of Inflammatory Bowel Disease (IBD) remains unclear. We aimed to establish a high-resolution immune landscape of treatment-naive IBD to identify central drivers of disease onset and early pathogenic signalling. Methods: We generated a single-cell atlas using intestinal biopsies from a large adult inception cohort of 137 individuals, including treatment-naive Crohn's disease (CD), ulcerative colitis (UC), and symptomatic non-IBD controls. We integrated scRNA-seq (1 million cells) with co-varying neighbourhood analysis (CNA) and unbiased tensor decomposition of cell-cell communication (CCC) networks. Findings were validated in vitro macrophage stimulation model and using serum from patients. Results: The inception cohort exhibited significantly more homogenous compartmental diversity compared to benchmark reference studies (p < 0.001). Inflammation in both CD and UC was characterized by a marked expansion of inflammatory monocytes. Unbiased CCC analysis identified a dominant disease-specific signalling module centred on the Galectin family (LGALS1 and LGALS9). Galectin-9 expression was specifically enriched in inflammatory monocytes, which exhibited distinct. transcriptional programs linked to antigen presentation and microbial sensing. In vitro, Galectin-9 acted as a potent stimulus, driving macrophages toward a pro-inflammatory phenotype. Clinically, serum Galectin-9 levels were significantly elevated in IBD patients and correlated with systemic inflammatory markers and treatment response. Conclusions: Our data identify a galectin-monocyte signalling axis as a unifying inflammatory hallmark of early IBD. Galectin-9 serves as both a functional driver of mucosal inflammation and a dynamic biomarker, offering new opportunities for therapeutic targeting and disease monitoring from diagnosis. Keywords: Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis; Single-cell RNA sequencing; Galectin-9; Inflammatory monocytes.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Gut
40 papers in training set
Top 0.1%
12.6%
2
Journal of Crohn's and Colitis
11 papers in training set
Top 0.1%
9.7%
3
Frontiers in Immunology
638 papers in training set
Top 1%
9.6%
4
Genome Medicine
183 papers in training set
Top 0.4%
6.7%
5
Nature Communications
5641 papers in training set
Top 27%
5.5%
6
JCI Insight
277 papers in training set
Top 2%
3.2%
7
Gastroenterology
42 papers in training set
Top 0.3%
3.2%
50% of probability mass above
8
Nature Immunology
79 papers in training set
Top 0.8%
3.2%
9
Inflammatory Bowel Diseases
16 papers in training set
Top 0.1%
3.2%
10
European Journal of Immunology
60 papers in training set
Top 0.5%
2.7%
11
Cell Reports
1498 papers in training set
Top 15%
2.4%
12
Scientific Reports
3612 papers in training set
Top 44%
2.4%
13
Nature Medicine
125 papers in training set
Top 1%
2.1%
14
Cell Death & Disease
21 papers in training set
Top 0.2%
1.7%
15
eLife
5828 papers in training set
Top 50%
1.7%
16
Cell Reports Medicine
153 papers in training set
Top 3%
1.3%
17
iScience
1154 papers in training set
Top 23%
1.3%
18
Journal of Allergy and Clinical Immunology
27 papers in training set
Top 0.3%
1.3%
19
Mucosal Immunology
47 papers in training set
Top 0.7%
1.1%
20
Immunity
67 papers in training set
Top 1%
1.1%
21
Gut Microbes
78 papers in training set
Top 1%
1.0%
22
Science Immunology
88 papers in training set
Top 2%
1.0%
23
Cell Communication and Signaling
51 papers in training set
Top 1%
1.0%
24
Cellular and Molecular Gastroenterology and Hepatology
46 papers in training set
Top 0.9%
0.8%
25
EMBO Molecular Medicine
95 papers in training set
Top 3%
0.8%
26
Journal of Clinical Investigation
179 papers in training set
Top 6%
0.8%
27
Gastro Hep Advances
11 papers in training set
Top 0.4%
0.6%
28
eBioMedicine
183 papers in training set
Top 8%
0.6%
29
Nature Genetics
286 papers in training set
Top 5%
0.6%
30
Cell
431 papers in training set
Top 11%
0.6%